The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: CARDIO IQR DIABETES AND ASCVD RISK PANEL WITH SCORES
The Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test contains 1 test with 21 biomarkers.
Brief Description: The Cardio IQ® Diabetes and ASCVD Risk Panel with Scores is a comprehensive diagnostic tool designed to simultaneously evaluate a patient's risk for diabetes and atherosclerotic cardiovascular disease (ASCVD). It combines markers associated with both conditions to provide an encompassing view of a patient's metabolic and cardiovascular health, further aiding in the identification of risks.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: If a cholesterol measurement is to be performed along with Triglycerides, but not part of a lipid panel, then the patient should be fasting 9-12 hours prior to collection. If the cholesterol is ordered as part of a lipid panel, then a fasting sample is not required.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.
This is a Cardio IQ™ test and will likely need an additional 5-7 days for processing.
IMPORTANT: For risk calculations to be performed, the following patient-specific information must be provided and recorded at the time of specimen collection:
Age: Years
Gender: M (for male) or F (for female)
Height Feet: Feet
Height Inches: Inches
Weight: lbs
Race-African American: Y (for yes) or N (for no)
Systolic Blood Pressure: mmHg
Diastolic Blood Pressure: mmHg
Treatment for High B.P.: Y (for yes) or N (for no)
Diabetes Status: Y (for yes) or N (for no)
Parental History of Diab: Y (for yes) or N (for no)
Smoking Status: Y (for Yes) or N (for no)
This test is particularly pertinent in several scenarios:
High-risk Groups: For individuals with known risk factors such as obesity, hypertension, family history of heart disease or diabetes, or other underlying health conditions.
Symptom Presentation: In patients showing symptoms of diabetes or cardiovascular issues, such as fatigue, frequent urination, chest pain, or shortness of breath.
Regular Health Screenings: Especially recommended for adults over a certain age or those with specific risk factors.
This panel is multifaceted and typically looks at:
Blood Sugar Markers: Such as fasting glucose and Hemoglobin A1c, indicating the body's ability to regulate sugar levels over short and long periods.
Cholesterol Levels: Including LDL, HDL, and triglycerides, which are directly linked to cardiovascular health.
Other Cardiovascular Markers: Like apolipoproteins, which can give a more detailed view of ASCVD risk.
The "scores" component quantifies the results into a risk percentage or numerical value, providing both the patient and healthcare provider with a digestible understanding of the individual's relative risk.
Blood Pressure Measurements: Given its direct correlation with cardiovascular health.
Kidney Function Tests: Such as serum creatinine or urine albumin, as both diabetes and cardiovascular disease can affect kidney health.
C-Reactive Protein Test: To measure inflammation, which can be a marker for cardiovascular disease risk.
Diabetes and Prediabetes: Identifying early signs or risk of developing the condition.
Atherosclerotic Cardiovascular Disease (ASCVD): Which includes conditions such as coronary artery disease, peripheral arterial disease, and stroke.
Metabolic Syndrome: A combination of conditions like hypertension, high blood sugar, and abnormal cholesterol or triglyceride levels, increasing the risk of chronic diseases.
These results are instrumental for healthcare providers to:
Risk Classification: Properly classify and educate patients on their risks, allowing for early interventions.
Formulate Treatment Plans: Interventions may range from lifestyle modifications and dietary changes to prescription medications.
Monitor Intervention Efficacy: Repeated tests can help evaluate if interventions or treatments are effectively reducing risk.
In essence, the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test is a critical tool that offers a two-pronged approach, targeting both diabetes and cardiovascular disease risks. This holistic view is essential for proactive healthcare, emphasizing prevention and early detection.
What is the primary purpose of the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test?
The Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test is primarily designed to assess an individual's risk for developing diabetes and atherosclerotic cardiovascular disease (ASCVD). It evaluates several biomarkers that are indicators of metabolic health and cardiovascular risk, thus providing a comprehensive outlook on an individual's health status.
Why might a healthcare provider recommend the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test?
Healthcare providers might recommend the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test for patients with a family history of diabetes or cardiovascular diseases, those presenting with risk factors for metabolic syndrome, or those who have lifestyle factors that might increase their risk for either condition. It offers a proactive approach to early detection, potentially allowing for timely interventions.
How do clinicians interpret the results of the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test?
The results of the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test provide scores that represent the relative risk of developing diabetes and ASCVD. Scores are categorized, often from low to high risk. The presence and levels of specific biomarkers also give insight into metabolic and cardiovascular health. Based on these scores and biomarker levels, clinicians can determine the need for preventive measures or further diagnostic tests.
If a patient receives a high risk score on the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test, what might be the subsequent medical recommendations?
A high-risk score suggests an elevated risk of developing diabetes or ASCVD. Medical recommendations might include lifestyle changes like adopting a heart-healthy diet, increasing physical activity, weight management, and potentially medications to address high blood pressure, cholesterol, or glucose levels. Regular follow-up and monitoring would also be essential.
Is the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test used as a sole diagnostic tool for diabetes and ASCVD?
No, the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test is a risk assessment tool and doesn't directly diagnose diabetes or ASCVD. A definitive diagnosis would require further clinical evaluations and other specific diagnostic tests.
What sets the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test apart from other risk assessment tests?
The Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test is unique in its comprehensive approach. Instead of focusing on a single marker or risk factor, it evaluates multiple biomarkers related to both diabetes and ASCVD. This holistic evaluation provides a broader understanding of an individual's health and risk factors.
Are there conditions or factors that might influence the results of the Cardio IQ® Diabetes and ASCVD Risk Panel with Scores test?
Indeed, certain conditions like polycystic ovary syndrome (PCOS), thyroid disorders, or having metabolic syndrome can influence the results. Lifestyle factors, such as diet, physical activity, and recent illnesses, as well as certain medications, might also affect the biomarkers evaluated by the test. It's crucial for individuals to provide a comprehensive medical history for accurate result interpretation.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.